ProShare Advisors’s Organon & Co OGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$423K Buy
+31,267
New +$374K ﹤0.01% 1200
2023
Q4
Sell
-96,039
Closed -$1.67M 1967
2023
Q3
$1.67M Buy
96,039
+55,520
+137% +$1.16M 0.01% 668
2023
Q2
$843K Buy
40,519
+1,227
+3% +$26.7K ﹤0.01% 760
2023
Q1
$924K Sell
39,292
-12,787
-25% -$343K ﹤0.01% 738
2022
Q4
$1.45M Sell
52,079
-607
-1% -$15.5K 0.01% 668
2022
Q3
$1.23M Sell
52,686
-3,085
-6% -$93.1K ﹤0.01% 697
2022
Q2
$1.88M Sell
55,771
-16,187
-22% -$567K 0.01% 656
2022
Q1
$2.51M Sell
71,958
-5,082
-7% -$174K 0.01% 683
2021
Q4
$2.35M Buy
77,040
+22,051
+40% +$718K ﹤0.01% 727
2021
Q3
$1.8M Sell
54,989
-39,211
-42% -$1.25M 0.01% 738
2021
Q2
$2.85M Buy
+94,200
New +$3.1M 0.01% 645

Other funds holding OGN

ProShare Advisors's OGN Position: Q2 2026 in Review

ProShare Advisors opened a new position in Organon & Co (OGN) in Q2 2026: 31,267 shares worth $423K. The stake represents ﹤0.01% of the portfolio and ranks #1200 among its holdings. This is a return to the name: ProShare Advisors previously reported a position in OGN as recently as Q3 2023.

ProShare Advisors first reported a position in OGN in Q2 2021 and has held it in 11 quarters since. The position peaked at $2.85M in Q2 2021. 631 funds tracked by Wall St. Rank hold OGN as of Q2 2026.

  • ProShare Advisors held 31,267 shares of Organon & Co worth $423K as of Q2 2026.
  • Organon & Co was a new ProShare Advisors position in Q2 2026.
  • Organon & Co made up ﹤0.01% of ProShare Advisors's portfolio in Q2 2026, its #1200 holding.
  • ProShare Advisors first reported a position in Organon & Co in Q2 2021 and has held it in 11 quarters since.
  • ProShare Advisors's Organon & Co position peaked at $2.85M in Q2 2021.
  • 631 funds tracked by Wall St. Rank held Organon & Co as of Q2 2026.

Based on ProShare Advisors's 13F filing for Q2 2026, filed 11 Aug 2026.